Current characteristics of chronic hepatitis B in Egypt

Background and aim In the era of hepatitis C virus eradication, Egypt had to pay attention to the two million infected with chronic hepatitis B. This study aimed to observe the current characteristics of chronic hepatitis B virus (HBV) infection in Egypt. Patients and methods This cross-sectional st...

Full description

Bibliographic Details
Main Authors: Maha M Elsabaawy, Mohammed E Elsherefy, Haitham E Sakr, Dalia Elsabaawy, Helmy Elshazly, Hossam Elezaawy, Gasser I Al Azab, Mahmoud Eltahawy
Format: Article
Language:English
Published: SpringerOpen 2019-01-01
Series:The Egyptian Journal of Internal Medicine
Subjects:
Online Access:http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=822;epage=830;aulast=Elsabaawy
_version_ 1818414318959460352
author Maha M Elsabaawy
Mohammed E Elsherefy
Haitham E Sakr
Dalia Elsabaawy
Helmy Elshazly
Hossam Elezaawy
Gasser I Al Azab
Mahmoud Eltahawy
author_facet Maha M Elsabaawy
Mohammed E Elsherefy
Haitham E Sakr
Dalia Elsabaawy
Helmy Elshazly
Hossam Elezaawy
Gasser I Al Azab
Mahmoud Eltahawy
author_sort Maha M Elsabaawy
collection DOAJ
description Background and aim In the era of hepatitis C virus eradication, Egypt had to pay attention to the two million infected with chronic hepatitis B. This study aimed to observe the current characteristics of chronic hepatitis B virus (HBV) infection in Egypt. Patients and methods This cross-sectional study was conducted on 183 patients with chronic HBV infection. The demographic, epidemiologic, clinical, laboratory, and treatment data were collected from patient registries. Results Positive hepatitis B e-antigen (HBeAg) cases represented 18.04%. They were younger (31.09±8.542–38.22±10.6 years) (P<0.05), with higher alanine aminotransferase (84.91±67.855–53.75±55.575 U/l) (P<0.05) and viral loads (3.58×108±16.49×108–1.74×106±10.1×106 IU/ml) (P<0.05), particularly in chronic active carrier states. Unsafe hygienic procedures (sharing toothbrushes and razors) were the main infective routes (73.7%). Coinfection with hepatitis C virus was documented in 14.7%, along with 16.3% with schistosomal infestation. HBV and hepatitis D virus coinfection was reported in 8.9% of the studied cohort. Radiologically, liver cirrhosis was detected in 44% of cases, with associated splenomegaly in 20.7%. Histologically, 40.2% were found to have significant pathology (A2, F2>2). Thirty (16.3%) cases were outside international guidelines of treatment, only for follow-up. Overall, 70.5% were subjected to lamidine therapy, with unfair responses mainly detected in the HBeAg-positive group (71.4%), who responded marvelously to interferon finite regimens. HBeAg-positive status and schistosomiasis were found to be associated with poor response to oral antivirals by multivariate analysis (P<0.05). Conclusion More classified governmental censorship efforts, notably on private organizations, along with awareness levitation are promptly mandated. Additionally, the poor response to oral antivirals in HBeAg-positive patients signifies sticking to interferon as a first-line treatment option.
first_indexed 2024-12-14T11:17:12Z
format Article
id doaj.art-5a8e3fe02d9c4eb6aee05f603308148f
institution Directory Open Access Journal
issn 1110-7782
2090-9098
language English
last_indexed 2024-12-14T11:17:12Z
publishDate 2019-01-01
publisher SpringerOpen
record_format Article
series The Egyptian Journal of Internal Medicine
spelling doaj.art-5a8e3fe02d9c4eb6aee05f603308148f2022-12-21T23:03:57ZengSpringerOpenThe Egyptian Journal of Internal Medicine1110-77822090-90982019-01-0131482283010.4103/ejim.ejim_70_19Current characteristics of chronic hepatitis B in EgyptMaha M ElsabaawyMohammed E ElsherefyHaitham E SakrDalia ElsabaawyHelmy ElshazlyHossam ElezaawyGasser I Al AzabMahmoud EltahawyBackground and aim In the era of hepatitis C virus eradication, Egypt had to pay attention to the two million infected with chronic hepatitis B. This study aimed to observe the current characteristics of chronic hepatitis B virus (HBV) infection in Egypt. Patients and methods This cross-sectional study was conducted on 183 patients with chronic HBV infection. The demographic, epidemiologic, clinical, laboratory, and treatment data were collected from patient registries. Results Positive hepatitis B e-antigen (HBeAg) cases represented 18.04%. They were younger (31.09±8.542–38.22±10.6 years) (P<0.05), with higher alanine aminotransferase (84.91±67.855–53.75±55.575 U/l) (P<0.05) and viral loads (3.58×108±16.49×108–1.74×106±10.1×106 IU/ml) (P<0.05), particularly in chronic active carrier states. Unsafe hygienic procedures (sharing toothbrushes and razors) were the main infective routes (73.7%). Coinfection with hepatitis C virus was documented in 14.7%, along with 16.3% with schistosomal infestation. HBV and hepatitis D virus coinfection was reported in 8.9% of the studied cohort. Radiologically, liver cirrhosis was detected in 44% of cases, with associated splenomegaly in 20.7%. Histologically, 40.2% were found to have significant pathology (A2, F2>2). Thirty (16.3%) cases were outside international guidelines of treatment, only for follow-up. Overall, 70.5% were subjected to lamidine therapy, with unfair responses mainly detected in the HBeAg-positive group (71.4%), who responded marvelously to interferon finite regimens. HBeAg-positive status and schistosomiasis were found to be associated with poor response to oral antivirals by multivariate analysis (P<0.05). Conclusion More classified governmental censorship efforts, notably on private organizations, along with awareness levitation are promptly mandated. Additionally, the poor response to oral antivirals in HBeAg-positive patients signifies sticking to interferon as a first-line treatment option.http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=822;epage=830;aulast=Elsabaawyalanine aminotransferasecharacteristicsegypthepatitis b e-antigenhepatitis b virusregimens and periodical follow-up for biochemicalvirologicaland e-antigen seroconversion
spellingShingle Maha M Elsabaawy
Mohammed E Elsherefy
Haitham E Sakr
Dalia Elsabaawy
Helmy Elshazly
Hossam Elezaawy
Gasser I Al Azab
Mahmoud Eltahawy
Current characteristics of chronic hepatitis B in Egypt
The Egyptian Journal of Internal Medicine
alanine aminotransferase
characteristics
egypt
hepatitis b e-antigen
hepatitis b virus
regimens and periodical follow-up for biochemical
virological
and e-antigen seroconversion
title Current characteristics of chronic hepatitis B in Egypt
title_full Current characteristics of chronic hepatitis B in Egypt
title_fullStr Current characteristics of chronic hepatitis B in Egypt
title_full_unstemmed Current characteristics of chronic hepatitis B in Egypt
title_short Current characteristics of chronic hepatitis B in Egypt
title_sort current characteristics of chronic hepatitis b in egypt
topic alanine aminotransferase
characteristics
egypt
hepatitis b e-antigen
hepatitis b virus
regimens and periodical follow-up for biochemical
virological
and e-antigen seroconversion
url http://www.esim.eg.net/article.asp?issn=1110-7782;year=2019;volume=31;issue=4;spage=822;epage=830;aulast=Elsabaawy
work_keys_str_mv AT mahamelsabaawy currentcharacteristicsofchronichepatitisbinegypt
AT mohammedeelsherefy currentcharacteristicsofchronichepatitisbinegypt
AT haithamesakr currentcharacteristicsofchronichepatitisbinegypt
AT daliaelsabaawy currentcharacteristicsofchronichepatitisbinegypt
AT helmyelshazly currentcharacteristicsofchronichepatitisbinegypt
AT hossamelezaawy currentcharacteristicsofchronichepatitisbinegypt
AT gasserialazab currentcharacteristicsofchronichepatitisbinegypt
AT mahmoudeltahawy currentcharacteristicsofchronichepatitisbinegypt